Gene Therapy for Beta Thalassemia: Compare Casgevy, Zynteglo, Aqvesme, Luspatercept and Future Options
Gene therapy for beta thalassemia is creating new possibilities for selected patients who depend on regular blood transfusions. Compare Casgevy and Zynteglo with Aqvesme, luspatercept, donor stem cell transplant and emerging treatments. Understand eligibility, expected outcomes, conditioning chemotherapy, recovery, fertility, safety monitoring, costs and the supportive role of individualized Ayurvedic care before choosing a treatment pathway.